Primary cultures of purified human cytotrophoblasts have been used to examine the expression of the corticotropin-releasing hormone (CRH) gene in placenta. We report here that glucocorticoids stimulate placental CRH synthesis and secretion in primary cultures of human placenta. This stimulation is in contrast to the glucocorticoid suppression of CRH expression in hypothalamus. The positive regulation of CRH by glucocorticoids suggests that the rise in CRH preceding parturition could result from the previously described rise in fetal glucocorticoids. Furthermore, this increase in placental CRH could stimulate, via adrenocorticotropic hormone, a further rise in fetal glucocorticoids, completing a positive feedback loop that would be terminated by delivery.
Corticotropin-releasing hormone (CRH), one ofthe hypothalamic components of the hypothalamic-pituitary-adrenal axis (1, 2) , is also present in human placenta, where its synthesis and secretion rise more than 20-fold in the 5 weeks preceding parturition (3, 4) . The secretion of glucocorticoids by the adrenal gland of the human fetus also increases markedly during this same period (5), although the manner in which glucocorticoids interact with placental CRH is not known. Defining the nature of this interaction is a prerequisite to determining the role of these hormones in human pregnancy. To examine the effect of glucocorticoids on placental CRH gene expression, we have purified and characterized cultures of human cytotrophoblasts and performed blot hybridization analysis of RNA isolated from cultured cells.
METHODS
Cytotrophoblast Purification and Immunocytochemistry. Full-gestation human placentae were obtained at elective Caesarean section, and cytotrophoblasts were enzymatically dispersed, purified by Percoll gradient centrifugation, and cultured as described (6) . For immunocytochemistry, cultures were washed in several changes of cold 0.01 M phosphate, pH 7.4/0.9% NaCl (PBS), and fixed for 10 min in cold acetone/methanol (1:1, vol/vol) or 2% paraformaldehyde in PBS. Slides were air dried and stored at -70°C until immunocytochemistry was performed. Acetone/methanolfixed cells were allowed to react with anti-cytotrophoblast monoclonal antibody 18B/A5 (kindly provided by Y. W. Loke, Univ. of Cambridge) (7) . Avidin-biotin-peroxidase (Vectastain, Burlingame, CA) and 0.05% diaminobenzidine (Sigma) were used to localize bound antibody. Paraformaldehyde-fixed cells were allowed to react with a polyclonal anti-placental alkaline phosphatase antiserum (Dako, Santa Barbara, CA) and horseradish peroxidase. All sections were lightly counterstained with Gill's hematoxylin.
Cell Culture. Cells were cultured at a density of 2 x 107 cells per 150-cm2 flask and were exposed to 1 AuM dexamethasone (Sigma) in absolute ethanol for either 4 hr (4-hr sample) or 24 hr (24-, 48-, and 72-hr samples) prior to trypsin digestion. Control cells were exposed to equal volumes of vehicle alone. All cells were released by brief exposure to 0.5% trypsin (Sigma) in calcium-and magnesium-free Hanks' balanced salt solution (GIBCO). Cells were spun at 2000 x g at 40C for 10 min and cell pellets were frozen at -700C.
RNA Isolation and Blot Hybridization. RNA was prepared from cell pellets (8) after the addition of 400 pg per cell pellet of a 400 nucleotide-long synthetic sense-strand CRH complementary RNA standard (9) tTo whom reprint requests should be addressed.
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extending from the end of the hybrid to the 3' terminus of CRH mRNA (Fig. 4a) . The site of CRH mRNA transcriptional initiation was deduced from the size of the 5' CRH mRNA fragment, the location of the region of DNA-RNA hybridization, and the human CRH gene DNA sequence (14) . Ten micrograms ofRNA was dissolved in 0.025 ml of 100 mM KCl/0.1 mM EDTA and mixed with 500 pmol of a synthetic oligodeoxynucleotide 23 bases in length and complementary to bases 470-492 of the human CRH gene (14) . The mixture was heated to 65TC for 2 min and incubated at room temperature for 30 min. RNase H (Bethesda Research Laboratories) at 40 units/mi in 0.025 ml of 10 mM MgCl2/80 mM KCl/1 mM dithiothreitol/0.5 mg ofbovine serum albumin per ml/50 mM Tris HCl, pH 7.5, was added, and the samples were incubated at 37TC for 30 min. RNA was extracted with phenol/chloroform, electrophoresed on a 5% acrylamide gel containing 7 M urea, and electroblotted onto GeneScreen (DuPont). RNA size markers were synthesized by using an RNA transcriptional vector into which was inserted a template encoding a rat CRH cDNA corresponding to nucleotides 175-2106 of the rat CRH gene (15) and one-way analysis of variance with post hoc comparison of means for more than two groups. All tests ofsignificance were two-tailed. Uncertainties are expressed as + SEM.
RESULTS
Human cytotrophoblast cells were purified (6) and cultured for up to 96 hr, and the morphological transformation from cytotrophoblast to syncytiotrophoblast was confirmed by immunocytochemical staining. Staining with the cytotrophoblast-specific monoclonal antibody, 18B/A5 (7), was restricted predominantly to single cells and diminished as cells differentiated into syncytiotrophoblast cells (Fig. 1 Left) . In contrast, staining with a polyclonal antiserum to placental alkaline phosphatase, which is specific for syncytiotrophoblast cells (16) , increased progressively during the period of culture, being absent from single cytotrophoblast cells and increasing in intensity as syncytiotrophoblast cells formed (Fig. 1 Right) .
Total mRNA was prepared from cultured trophoblasts and analyzed by blot hybridization. Blots were probed for mRNAs encoding CRH, GR, and /32m, the latter being the constitutively expressed cell surface component of the major histocompatibility locus (17) . CRH mRNAs in cultured trophoblast and term placenta were similar in size (Fig. 2) . In three separate placental preparations, CRH mRNA was pres- ent in both cytotrophoblast and syncytiotrophoblast; peak levels (3.5 ± 0.3-fold above baseline, P < 0.005) occurred after 24 hr in culture (Fig. 2) , during the major period of transition from cytotrophoblast to syncytiotrophoblast. These observations are similar to those made in previous studies of human chorionic gonadotropin mRNA expression (18) . The levels of GR and f32m mRNA (Fig. 2) remained stable during the period of culture, indicating both the viability ofthe cultured cells and the specificity of the observed rise in CRH mRNA content.
After various times in culture, cells were exposed to dexamethasone, 1 ,uM, for 24 hr (Fig. 3) . Dexamethasone treatment was associated with a 2-to 5-fold increase in CRH mRNA content and CRH peptide secretion into media from cells cultured for 24-72 hr (Fig. 3 a and b) . In quadruplicate preparations of cells cultured for 24 hr in the presence of dexamethasone (Fig. 3 c and d ), CRH mRNA increased 3.7-fold (P < 0.001) and CRH peptide secretion increased 2.3-fold (P < 0.001). In cultures of four additional placentae (each assayed in duplicate), CRH mRNA at 24 (Fig. 4a) , as determined from identification of a major 5' CRH mRNA fragment, 136 nucleotides long (Fig. 4b, - (Fig. 4b, + lane) (Fig. 3) , consistent with the possibility that fetal glucocorticoids stimulate placental CRH expression in vivo. Furthermore, since (i) biologically active placental CRH is secreted into the fetal circulation (23) , (it) CRH is able to stimulate ACTH release from human fetal pituitary (24) , and (iii) fetal adrenal steroidogenesis is stimulated by ACTH (25) , the increase in placental CRH could stimulate, via ACTH, a further rise in fetal glucocorticoids, completing a positive feedback loop (Fig. 5) . Furthermore, placental CRH could act in a paracrine manner to stimulate local ACTH (28) or human chorionic gonadotropin (29) production by the trophoblast. Extrinsic factors, such as maternal or fetal stress, could also potentially modulate this axis (Fig. 5) . It is of interest to note that the only other positive feedback system to be well characterized among steroid hormones is the stimulatory effect of ovarian estrogens on the midcycle surge of luteinizing hormone (30) . Positive feedback is terminated in this system by ovulation, and it is terminated in the fetoplacental system by parturition.
Glucocorticoid classically down-regulates GR, which is the limiting factor governing the response of a gene to the steroid (31 mRNA content is consistent with the presence of a CRHglucocorticoid positive feedback loop in the fetoplacental unit. This response is very different from the fall in GR mRNA caused by dexamethasone in a variety of rat tissues (32) and mouse anterior pituitary cells (G. Adler and J.A.M., unpublished observations). Because progesterone is known to bind to GR (33) , and its production by the trophoblast rises progressively during gestation (34), we examined the effect of progesterone treatment on the levels of GR and CRH mRNA in cultured trophoblast cells. Progesterone at 1-100 nM had no effect on the levels of these mRNAs in this system (B.G.R., unpublished observations).
Glucocorticoid has opposite effects on the regulation of CRH in placenta and hypothalamus. In both sites, CRH is a product of the same gene, located on the long arm of chromosome eight (35) . In placental cultures, glucocorticoid stimulates an increase in CRH mRNA transcribed from an initiation site 30 nucleotides downstream from a consensus promoter element (Fig. 4) (36) . The role played by fetal adrenal steroidogenesis in human parturition is unknown. Studies of fetal anencephaly in humans (37) suggest that the proper timing of parturition depends upon the presence of an intact fetal hypothalamicpituitary-adrenal axis. Glucocorticoids play an important role in the maturation of many fetal organ systems (38) . An attractive feature of the fetoplacental CRH-glucocorticoid hypothesis is that fetal maturation and timing of parturition would, under most circumstances, be coupled. Such a relationship would be advantageous for neonatal survival. Further studies are necessary to determine the in vivo characteristics of this positive feedback loop and whether it has a physiological role in fetal maturation or parturition.
